These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 156231)

  • 21. Letter: Schistosomiasis, immunosuppression and niridazole.
    Higashi GI; Gheith H; Farid Z; Miner WF
    N Engl J Med; 1975 Sep; 293(10):506. PubMed ID: 1080247
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of niridazole as a suppressant of cellular immunity in chickens.
    Walser MM
    Am J Vet Res; 1978 Nov; 39(11):1858-60. PubMed ID: 736345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Humoral inhibitors of the immune response in uremia. II. Further characterization of an immunosuppressive factor in uremic serum.
    Raskova J; Morrison AB; Shea SM; Raska K
    Am J Pathol; 1979 Nov; 97(2):277-90. PubMed ID: 230740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional characteristics of TG and TnonG cells in a three party MLR.
    Gebel HM; Radaj PA; Holmes D; Schwartz BD; Rodey GE
    J Immunol; 1981 Jan; 126(1):118-21. PubMed ID: 6450233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunosuppression by human seminal plasma fractionated by DEAE Sephadex A-50 ion exchange chromatography.
    Haq A; al-Tufail M; Sheth K; Abdullatif M; Hamilton C; al-Abdul Jabbar F; al-Sedairy S
    Andrologia; 1992; 24(2):87-93. PubMed ID: 1534970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excretion of mutagens in sweat and faeces of man, and in serum, gastric juice and urine of rats, after oral dosing of niridazole or metronidazole.
    Mohtashamipur E; Norpoth K
    Mutagenesis; 1986 Sep; 1(5):371-4. PubMed ID: 3331676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Niridazole inhibition of local graft-versus-host reaction in rat muscle.
    Mottironi VD; Rudofsky UH; Swift RV; Esposito LL
    Clin Immunol Immunopathol; 1978 Jun; 10(2):158-67. PubMed ID: 27324
    [No Abstract]   [Full Text] [Related]  

  • 29. The rat mixed lymphocyte reaction: roles of a dendritic cell in intestinal lymph and T-cell subsets defined by monoclonal antibodies.
    Mason DW; Pugh CW; Webb M
    Immunology; 1981 Sep; 44(1):75-87. PubMed ID: 6456222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Host immunosuppression following orthotopic bowel allotransplantation in rats using low-dose cyclosporine.
    Grogan JB; Shimazu R; Masaki Y; Raju S
    Transplant Proc; 1991 Feb; 23(1 Pt 1):870-2. PubMed ID: 1825006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1-thiocarbamoyl-2-imidazolidinone, a metabolite of niridazole in Schistosoma mansoni.
    Catto BA; Tracy JW; Webster LT
    Mol Biochem Parasitol; 1984 Jan; 10(1):111-20. PubMed ID: 6546409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical effects of niridazole. II. In vitro and in vivo effects of niridazole on the rate of gluconeogenesis and the rate of oxidation of pyruvate and some Krebs cycle intermediates in Schistosoma mansoni infected mice.
    Sharaf AA; Khayyal MT; Kheir-el-Din A; Sharaf AA; Kassem F
    Egypt J Bilharz; 1978; 5(1-2):59-69. PubMed ID: 555755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Niridazole, a potent long-acting suppressant of cellular hypersensitivity. III. Minimal suppression of antibody responses.
    Pelley RP; Pelley RJ; Stavitsky AB; Mahmoud AA; Warren KS
    J Immunol; 1975 Dec; 115(6):1477-82. PubMed ID: 1184961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of lipids in the immune response. I. Localization to a lipid-containing fraction of the active moiety of an inhibitor (SIF) of lymphocyte proliferation.
    Wolf RL; Merler E
    J Immunol; 1979 Sep; 123(3):1169-74. PubMed ID: 157370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The formation of 1-thiocarbamoyl-2-imidazolidinone from niridazole in mouse intestine.
    Tracy JW; Webster LT
    J Pharmacol Exp Ther; 1981 May; 217(2):363-8. PubMed ID: 6894465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Niridazole-induced red/brown urine pigment is associated with increased urinary beta-glucuronidase excretion and a bladder site of formation.
    West BC
    Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):107-17. PubMed ID: 3086953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mixed lymphocyte reaction supernatants exert varied effects upon gingival fibroblasts in vitro.
    Al-Dallal A; Singh G; Matthews N; Dolby AE
    J Clin Lab Immunol; 1985 Dec; 18(4):183-6. PubMed ID: 2937920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune properties of human umbilical cord Wharton's jelly-derived cells.
    Weiss ML; Anderson C; Medicetty S; Seshareddy KB; Weiss RJ; VanderWerff I; Troyer D; McIntosh KR
    Stem Cells; 2008 Nov; 26(11):2865-74. PubMed ID: 18703664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of the mixed lymphocyte reaction by alloantigen-primed and -stimulated human spleen lymphocytes.
    Akbar AN; Jones DB
    Immunology; 1984 Feb; 51(2):361-6. PubMed ID: 6229476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.